Adria Cimino
Adria Cimino is a contributing Stock Market Analyst at The Motley Fool covering publicly traded companies in the healthcare, technology, and consumer goods industries. Prior to The Motley Fool, Adria covered the European stock market and U.S. stocks pre-market trading for Bloomberg News, Bloomberg TV, and Bloomberg Radio for more than a decade. Earlier in her career, she wrote about biotech, medtech, and technology companies in Boston for Mass High Tech, an American City Business Journals publication. She holds a B.A. in Mass Communications from the University of South Florida in Tampa. Fun fact: A few years ago, Adria co-founded a small publishing house specializing in women’s fiction, and published the fiction of about a dozen female authors. You’ll also find a few of her own novels, including “Paris, Rue des Martyrs,” on Amazon.
Recent Articles by Adria Cimino

Is Nvidia Stock Your Ticket to Becoming a Millionaire?

Better High-Growth AI Buy: Nvidia vs. CoreWeave

My Top 5 AI Stocks to Buy Before the Second Half

Is CoreWeave a Buy?

Down 12%, Should You Buy the Dip on Eli Lilly?

Is it Time to Dump Your Shares of Moderna?

Where Will Nvidia Be in 3 Years?

Is IonQ Stock a Buy Now?

Could Buying Palantir Today Set You Up for Life?

Here's Why GameStop Stock Is Plunging
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.